Artificial Intelligence Model-Assisted Accurate Diagnosis of Early-Stage Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

900

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

October 31, 2026

Conditions
Breast Cancer, MetastaticArtifical Intelligence
Interventions
OTHER

bulid primary AI model

For the collected patient data, deep learning is used to perform feature screening on the selected or collected images, and malignant risk factors are determined by combining clinical significance. A neural network classifier is trained on the training set data. Variable selection: independent variables (breast MRI images, breast ultrasound images, indicators such as CA199, CA153, CA125, AFP/CEA, etc.), dependent variables (whether suffering from breast cancer and breast cancer subtypes), and the verification accuracy standard is set as the pathological biopsy result.

OTHER

verdict model and develop its function

The accuracy of a breast cancer prediction model is typically evaluated using multiple metrics that assess its performance in different aspects

Trial Locations (1)

Unknown

Army medical Cnter, Chongqing

All Listed Sponsors
lead

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

OTHER